搜索筛选:
搜索耗时0.1498秒,为你在为你在102,285,761篇论文里面共找到 13 篇相符的论文内容
发布年度:
[期刊论文] 作者：Yan Wang,Lin Shen,Nong Xu,Jin-,
来源：世界胃肠病学杂志：英文版 年份：2012
瞄准：为了评估，在变形 colorectal 癌症(mCRC ) 在 irinotecan 上 UDP-glucuronosyltransferase1A1 (UGT1A1 ) 和 thymidylate 合成酶(TS ) 完成基因多型性。方法：二基于 irinot...
[会议论文] 作者：Xin Xu,Chenyu Mao,Nong Xu,Jiang Cao,Lisong Teng,
来源：第十二届国际胃癌学术会议 年份：2017
...
Impact of a Low Preoperative Body Mass Index on the Postoperative Complications and Overall Survival
[期刊论文] 作者：Huan Wang,Chen Yu Mao,Jing Deng,Xi Jin,Nong Xu,
来源：肿瘤营养学杂志（英文） 年份：2019
Objective Obesity is related to various diseases and the risk of cancer. However, most studies overemphasize the risk of obesity, while ignoring the impact of u...
[期刊论文] 作者：Yan Wang,Lin Shen,Nong Xu,Jin-Wan Wang,Shun-Chang Jiao,Ze-Yuan Liu,Jian-Ming Xu,,
来源：World Journal of Gastroenterology 年份：2012
AIM:To evaluate effects of UDP-glucuronosyltransferase1A1(UGT1A1) and thymidylate synthetase(TS) gene polymorphisms on irinotecan in metastatic colorectal cance...
RRM1 gene expression in peripheral blood is predictive of shorter survival in Chinese advanced non-s
[会议论文] 作者：Lin-ran Wang,Guo-bing Zhang,Jian Chen,Jun Lee,Ming-wei Li,Nong Xu,Yang Wang,Jian-zhong SHEN TU,
来源：2011年浙江省医院药学学术研讨会暨年会 年份：2011
Objective To investigate the clinical predictive significance of ribonucleotide reductase Ml (RRM1) and breast cancer susceptibility gene l(BRCA1) gene expressi...
[会议论文] 作者：Chenyu Mao,Yao Wang,Yulong Zheng,Haiping Jiang,Jiong Qian,Jing Deng,Genming Shi,Lisong Teng,Nong Xu,
来源：第十二届国际胃癌学术会议 年份：2017
...
Phase Ⅱ study of oxaliplatin combined with S-1 and leucovorin (SOL) for Chinese patients with metast
[期刊论文] 作者：Zhi-Qiang Wang,Dong-Sheng Zhang,Nong Xu,De-Yun Luo,Yan-Hong Deng,Feng-Hua Wang,Hui-Yan Luo,Miao-Zhen,
来源：Chinese Journal of Cancer 年份：2016
Background:Fluoropyrimidine and oxaliplatin are widely used for patients with colorectal cancer.This phase II study was conducted to evaluate the efficacy and s...
[会议论文] 作者：Zheng,Jiong Qian,Haiping Jiang,Chenyu Mao,Peng Zhao,Yi Zheng,Xiaochen Zhang,Weijia Fang,Peng Shen,Nong Xu,
来源：第十六届全国临床肿瘤学大会暨2013年CSCO学术年会 年份：2013
...
Phase Ⅱ study of oxaliplatin combined with S-1 and leucovorin(SOL)for Chinese patients with metastat
[会议论文] 作者：Zhi-Qiang Wang,Yu-Hong Li,Feng-Hua Wang,Dong-Sheng Zhang,Rui-Hua Xu,Hui-Yan Luo,Miao-Zhen Qiu,Nong Xu,
来源：第四届广州国际肿瘤学会议 年份：2015
Introduction: Fluoropyrimidine and oxaliplatin are widely used for patients with colorectal cancer....
Phase Ⅱ study of oxaliplatin combined with S-1 and leucovorin(SOL)for Chinese patients with metastat
[会议论文] 作者：Zhi-Qiang Wang,Dong-Sheng Zhang,Nong Xu,De-Yun Luo,Yan-Hong Deng,Feng-Hua Wang,Hui-Yan Luo,Miao-Zhen,
来源：第四届广州国际肿瘤学会议 年份：2015
Introduction: Fluoropyrimidine and oxaliplatin are widely used for patients with colorectal cancer....
A randomized,double-blind,multicenter,Phase2,three-arm,placebo-control study of apatinib as third li
[会议论文] 作者：Nong Xu,Ying Cheng,Zhehai Wang,Leizhen Zheng,Min Tao,xiaodong Zhu,Dongmei Ji,Xin Liu,weijian Guo,Jianping,
来源：第十五届全国临床肿瘤学大会暨2012年CSCO学术年会 年份：2012
...
A randomized,double-blind,multicenter,Phase2,three-arm,placebo-control study of apatinib as third li
[会议论文] 作者：Jin Li,Nong Xu,Ying Cheng,Zhehai Wang,Leizhen Zheng,Min Tao,xiaodong Zhu,Dongmei Ji,Xin Liu,Shukui Qin,
来源：第十五届全国临床肿瘤学大会暨2012年CSCO学术年会 年份：2012
...
An open-label, randomized, multicenter study of S-1 vs Gemcitabine in patient with advanced pancreat
[会议论文] 作者：Jianming Xu,Yan Sun,Liwei Wang,Ruihua Xu,Yi Ba,Lin Shen,Shukui Qin,Nong Xu,Li Bai,Jin Li,Chunmei Bai,,
来源：第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份：2015
Objective: Gemcitabine (GEM) is a standard treatment in patients with advanced pancreatic cancer (PC).S-1 has shown a good efficacy and well safety in Japanese patients from previous studies and has b...
相关搜索：
